Philippe Albert Clevenbergh

3.7k citations
81 papers · 3.0k · 2 hit papers · h-index 20

Impact in

Papers in

    • HIV/AIDS drug development and treatment 20
    • HIV/AIDS Research and Interventions 14
    • Tuberculosis Research and Epidemiology 5
    • COVID-19 Clinical Research Studies 4
    • HIV Research and Treatment 12
    • Rabies epidemiology and control 3

Philippe Albert Clevenbergh

75 papers receiving 2.9k citations

Philippe Albert Clevenbergh's Hit Papers

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial 2020 · 388 citations
3880+9+18Years since publication200400600

Peers

Philippe Albert Clevenbergh
Comparison fields: 5 of 126
  • Virology 1.0k
  • Applied Microbiology and Biotechnology 215
  • Infectious Diseases 1.8k
  • Molecular Medicine 348
  • Critical Care and Intensive Care Medicine 87
Replace James W. T. Cohen Stuart with:
James W. T. Cohen Stuart Netherlands
Hedy Teppler United States
Simon Portsmouth United States
Raph L Hamers United Kingdom
Robert C. Kalayjian United States
Javier Murillas Spain
Henri Portier France
Athanasios T. Skoutelis Greece
Willy K Urassa Tanzania
Juan Pasquau Spain
Philippe Albert Clevenbergh relative to James W. T. Cohen Stuart Netherlands James W. T. Cohen Stuart's profile →
Citations per field
00.5×2×3×3.7×
James W. T. Cohen Stuart · 1×
Citations per year

Countries citing papers authored by Philippe Albert Clevenbergh

Since Specialization
Citations

This map shows the geographic impact of Philippe Albert Clevenbergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Albert Clevenbergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Albert Clevenbergh more than expected).

Fields of papers citing papers by Philippe Albert Clevenbergh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Albert Clevenbergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Albert Clevenbergh. The network helps show where Philippe Albert Clevenbergh may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Albert Clevenbergh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Albert Clevenbergh Line = papers co-authored together Philippe Albert Clevenbergh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial
Hit paper breakdown →
1999618
2
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Hit paper breakdown →
2020388
3 2000302
4 1999223
5 2000194
6 2004118
7 2000101
8 200098
9 200282
10 199781
11 200665
12 200660
13 202156
14 200244
15 201434
16 200033
17 202132
18 200429
19 200325
20 202025

About Philippe Albert Clevenbergh

Philippe Albert Clevenbergh is a scholar working on Infectious Diseases, Virology, Epidemiology, Microbiology and Endocrinology, having authored 81 papers that have together received 3.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), HIV/AIDS Research and Interventions (14 papers), HIV Research and Treatment (12 papers), Tuberculosis Research and Epidemiology (5 papers), COVID-19 Clinical Research Studies (4 papers), Streptococcal Infections and Treatments (4 papers), Rabies epidemiology and control (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Virology (1.0k citations), Applied Microbiology and Biotechnology (215 citations), Infectious Diseases (1.8k citations), Molecular Medicine (348 citations) and Critical Care and Intensive Care Medicine (87 citations). Philippe Albert Clevenbergh has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include P. Dellamonica, Jacques Durant, Philippe Halfon, Nathalie Montagne, CAB Boucher, Pascal Del-Giudice, Pere Simonet, R. Garraffo, Marc Jean Struelens and Pascal Del Giudice. Their work appears in journals such as Antiviral Therapy, Scandinavian Journal of Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, HIV Clinical Trials and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact